Ghent University Academic Bibliography

Your filters: cql: author="Chuang, Chien‐Chia" or (type any "bookEditor issueEditor" and editor="Chuang, Chien‐Chia")

Add to list
- Journal Article
- A1
- open access
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

Philippe Gevaert (UGent) , Stella E Lee, Russell A Settipane, Martin Wagenmann, Jérôme Msihid, Shahid Siddiqui, Scott Nash, Juby A Jacob‐Nara, Asif Khan, Siddhesh Kamat, et al.

(2023) CLINICAL & TRANSLATIONAL IMMUNOLOGY. 12(1).
Add to list
- Journal Article
- A1
- open access
Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Chien‐Chia Chuang, Isabelle Guillemin, Claus Bachert (UGent) , Stella E. Lee, Peter Hellings (UGent) , Wytske J. Fokkens, Nicolas Duverger, Chunpeng Fan, Nadia Daizadeh, Nikhil Amin, et al.

(2022) LARYNGOSCOPE. 132(2). p.259-264
Add to list
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Claus Bachert (UGent) , Anju T. Peters, Enrico Heffler, Joseph K. Han, Heidi Olze, Oliver Pfaar, Chien‐Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2022) CLINICAL AND EXPERIMENTAL ALLERGY. 52(2). p.244-249
Add to list
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Joseph K. Han, Claus Bachert (UGent) , Stella E. Lee, Claire Hopkins, Enrico Heffler, Peter Hellings (UGent) , Anju T. Peters, Siddhesh Kamat, Diane Whalley, Shanshan Qin, et al.

(2022) LARYNGOSCOPE. 132(2). p.265-271
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien-Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Conference Paper
- C3
Health-related quality of life impairment among patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 trial

Jorge Maspero, Carl Philpott, Peter Hellings (UGent) , Claire Hopkins, Martin Wagenmann, Shahid Siddiqui, Juby Jacob-Nara, Jerome Msihid, Chien-Chia Chuang, Siddhesh Kamat, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB133-AB133
Add to list
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

Anju T. Peters, Joseph K. Han, Peter Hellings (UGent) , Enrico Heffler, Philippe Gevaert (UGent) , Claus Bachert (UGent) , Yingxin Xu, Chien-Chia Chuang, Binod Neupane, Jérôme Msihid, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 9(6). p.2461-2471.e5
Add to list
A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Claus Bachert (UGent) , Anju Peters, Enrico Heffler, Joseph Han, Heidi Olze, Oliver Pfaar, Chien-Chia Chuang, Raj Rout, Richa Attre, Ledia Goga, et al.

(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB132-AB132

Academic Bibliography

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps

Dupilumab in CRSwNP : responder analysis using clinically meaningful efficacy outcome thresholds

Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient‐reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS‐24 and SINUS‐52 studies

Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis

Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Health-related quality of life impairment among patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 trial

Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps

A responder analysis to demonstrate Dupilumab treatment effect across objective and patient-reported subjective endpoints for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP)

Contents

Support

Contact